
Charanjit Aulakh
Examiner (ID: 11601)
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1612, 1203, 1621 |
| Total Applications | 3765 |
| Issued Applications | 2855 |
| Pending Applications | 383 |
| Abandoned Applications | 582 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9546813
[patent_doc_number] => 20140171461
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-19
[patent_title] => 'Nitrogen Containing Morphinan Derivatives and the Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/105724
[patent_app_country] => US
[patent_app_date] => 2013-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40968
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14105724
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/105724 | Nitrogen containing morphinan derivatives and the use thereof | Dec 12, 2013 | Issued |
Array
(
[id] => 9469254
[patent_doc_number] => 08722885
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-05-13
[patent_title] => 'Phosphorescent four-coordinated platinum (II) complex'
[patent_app_type] => utility
[patent_app_number] => 14/099476
[patent_app_country] => US
[patent_app_date] => 2013-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3576
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14099476
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/099476 | Phosphorescent four-coordinated platinum (II) complex | Dec 5, 2013 | Issued |
Array
(
[id] => 9538412
[patent_doc_number] => 20140163058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'BUPRENORPHINE ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 14/096311
[patent_app_country] => US
[patent_app_date] => 2013-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27877
[patent_no_of_claims] => 64
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14096311
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/096311 | Buprenorphine analogs | Dec 3, 2013 | Issued |
Array
(
[id] => 10554773
[patent_doc_number] => 09278968
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-03-08
[patent_title] => 'Imidazopyridine compounds'
[patent_app_type] => utility
[patent_app_number] => 14/428798
[patent_app_country] => US
[patent_app_date] => 2013-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 34267
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428798
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/428798 | Imidazopyridine compounds | Nov 27, 2013 | Issued |
Array
(
[id] => 9882603
[patent_doc_number] => 08969368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-03
[patent_title] => 'Crystalline, anhydrous forms of oxymorphone hydrochloride'
[patent_app_type] => utility
[patent_app_number] => 14/091399
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 4532
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091399
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/091399 | Crystalline, anhydrous forms of oxymorphone hydrochloride | Nov 26, 2013 | Issued |
Array
(
[id] => 9384648
[patent_doc_number] => 20140088130
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-27
[patent_title] => 'HEXAHYDRODIBENZO[A,G]QUINOLIZINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/091979
[patent_app_country] => US
[patent_app_date] => 2013-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19982
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14091979
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/091979 | HEXAHYDRODIBENZO[A,G]QUINOLIZINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | Nov 26, 2013 | Abandoned |
Array
(
[id] => 9370347
[patent_doc_number] => 20140080220
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-20
[patent_title] => 'Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions'
[patent_app_type] => utility
[patent_app_number] => 14/085058
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16937
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14085058
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/085058 | Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions | Nov 19, 2013 | Issued |
Array
(
[id] => 10898343
[patent_doc_number] => 08921558
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions'
[patent_app_type] => utility
[patent_app_number] => 14/084851
[patent_app_country] => US
[patent_app_date] => 2013-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 16957
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14084851
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/084851 | Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions | Nov 19, 2013 | Issued |
Array
(
[id] => 10422474
[patent_doc_number] => 20150307486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-29
[patent_title] => 'ERGOLINE DERIVATIVES AS DOPAMINE RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/443576
[patent_app_country] => US
[patent_app_date] => 2013-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8125
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14443576
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/443576 | Ergoline derivatives as dopamine receptor modulators | Nov 18, 2013 | Issued |
Array
(
[id] => 9491674
[patent_doc_number] => 20140142080
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => 'NOVEL GOLD(III) COMPLEXES CONTAINING N-HETEROCYCLIC CARBENE LIGAND, SYNTHESIS, AND THEIR APPLICATIONS IN CANCER TREATMENT AND THIOL DETECTION'
[patent_app_type] => utility
[patent_app_number] => 14/078742
[patent_app_country] => US
[patent_app_date] => 2013-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 14943
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14078742
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/078742 | Gold(III) complexes containing N-heterocyclic carbene ligand, synthesis, and their applications in cancer treatment and thiol detection | Nov 12, 2013 | Issued |
Array
(
[id] => 10122423
[patent_doc_number] => 09156772
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Fluoride-releasing compositions'
[patent_app_type] => utility
[patent_app_number] => 14/077279
[patent_app_country] => US
[patent_app_date] => 2013-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9947
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14077279
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/077279 | Fluoride-releasing compositions | Nov 11, 2013 | Issued |
Array
(
[id] => 10115714
[patent_doc_number] => 09150585
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Analogs of camptothecin'
[patent_app_type] => utility
[patent_app_number] => 14/076310
[patent_app_country] => US
[patent_app_date] => 2013-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22302
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14076310
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/076310 | Analogs of camptothecin | Nov 10, 2013 | Issued |
Array
(
[id] => 10389878
[patent_doc_number] => 20150274885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'PHOTORESPONSIVE COUMARIN BASED POLYMERS: SYNTHESIS AND APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 14/440645
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9746
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14440645
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/440645 | Photoresponsive coumarin based polymers: synthesis and applications | Nov 7, 2013 | Issued |
Array
(
[id] => 11408899
[patent_doc_number] => 09556192
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-01-31
[patent_title] => 'Functionalized 9-bromo-camptothecin derivatives'
[patent_app_type] => utility
[patent_app_number] => 14/439020
[patent_app_country] => US
[patent_app_date] => 2013-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17572
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14439020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/439020 | Functionalized 9-bromo-camptothecin derivatives | Oct 28, 2013 | Issued |
Array
(
[id] => 10389755
[patent_doc_number] => 20150274762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-01
[patent_title] => 'METAL COMPLEXES, METHODS, AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/437963
[patent_app_country] => US
[patent_app_date] => 2013-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 10064
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437963
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437963 | METAL COMPLEXES, METHODS, AND USES THEREOF | Oct 24, 2013 | Abandoned |
Array
(
[id] => 10406622
[patent_doc_number] => 20150291631
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-15
[patent_title] => 'A NOVEL LIGAND COMPOUND, A PREPARATION METHOD THEREOF, A TRANSITION METAL COMPOUND INCLUDING THE LIGAND COMPOUND, AND A PREPARATION METHOD THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/441418
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6656
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14441418
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/441418 | Ligand compound, a preparation method thereof, a transition metal compound including the ligand compound, and a preparation method thereof | Oct 22, 2013 | Issued |
Array
(
[id] => 9589596
[patent_doc_number] => 08779136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-15
[patent_title] => 'Process for preparing amines from alcohols and ammonia'
[patent_app_type] => utility
[patent_app_number] => 14/058191
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9602
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14058191
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/058191 | Process for preparing amines from alcohols and ammonia | Oct 17, 2013 | Issued |
Array
(
[id] => 9589593
[patent_doc_number] => 08779134
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-07-15
[patent_title] => 'Six-coordinated ruthenium complex'
[patent_app_type] => utility
[patent_app_number] => 14/057263
[patent_app_country] => US
[patent_app_date] => 2013-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12768
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14057263
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/057263 | Six-coordinated ruthenium complex | Oct 17, 2013 | Issued |
Array
(
[id] => 10374318
[patent_doc_number] => 20150259325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'INHIBITORS OF BETA-SECRETASE'
[patent_app_type] => utility
[patent_app_number] => 14/431588
[patent_app_country] => US
[patent_app_date] => 2013-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9255
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14431588
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/431588 | Inhibitors of β-secretase | Sep 24, 2013 | Issued |
Array
(
[id] => 10597619
[patent_doc_number] => 09318716
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-04-19
[patent_title] => 'Process for making electronically active functionalized silsequioxane nanostructures of controlled morphology through covalent synthesis'
[patent_app_type] => utility
[patent_app_number] => 14/032650
[patent_app_country] => US
[patent_app_date] => 2013-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 10065
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14032650
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/032650 | Process for making electronically active functionalized silsequioxane nanostructures of controlled morphology through covalent synthesis | Sep 19, 2013 | Issued |